tiprankstipranks
Trending News
More News >
Newamsterdam Pharma Company N.V. (NAMS)
:NAMS
US Market
Advertisement

NewAmsterdam Pharma Company (NAMS) Revenue

Compare
239 Followers

NewAmsterdam Pharma Company Revenue

NewAmsterdam Pharma Company had a revenue of 348.00K in the quarter ending Sep 30, 2025, with -98.18%. This bring the company's revenue in the last twelve months to 35.24M, Increased -44.94%. In the fiscal year ending Dec 31, 2024, NewAmsterdam Pharma Company had annual revenue of 45.56M with 223.37% growth.
Revenue (ttm)
35.24M
Revenue Growth
P/S Ratio
103.15
Revenue/Employee
$670,044
Employees
68
Market Cap
$4.70B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
45.56M31.47M+323.37%
Dec 31, 2023
14.09M-88.60M+13.72%
Dec 31, 2022
102.69M-10,269,400,000.00%
Dec 31, 2021
Dec 31, 2020
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis